Sebastian Goy | COO
EBViously (in formation)

Sebastian Goy, COO, EBViously (in formation)

Dr. Sebastian Goy will act as Chief Operational Officer of EBViously, a planned preclinical start-up company focusing on a novel virus-like particle based vaccine to prevent Epstein-Barr-associated disease.
He has worked in the field of new drug candidates, their preclinical development and translation for more than 8 years focusing on biologicals and novel vaccines. Currently, Sebastian is senior scientific project manager at the German Center for Infection Research (DZIF) in Braunschweig, Germany.
Sebastian received a Master of Science in Biomedicine in 2010 and a Doctorate in Molecular Medicine at the Hannover Biomedical Research School in 2014.


Day 3 - November 30 @ 11:15

Sera from mice vaccinated with Epstein-Barr virus-like particles potently prevent infection of human B cells and epithelial cells in vitro

last published: 02/Jan/24 12:15 GMT

back to speakers